Docket Room.
SB 351·AL·senate

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

FailedFiled Mar 10, 2026
Sponsor: April Weaver (R)
Latest Action

Currently Indefinitely Postponed

Apr 7, 2026

Email me when SB 351 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 351. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would let any FDA‑approved single‑dose pre‑measured epinephrine product, not just autoinjectors, be carried, stocked, and used by K‑12 schools, authorized entities and certain staff. It creates prescription, dispensing, storage, training and immunity rules, and would become effective on October 1, 2026. The measure failed and is indefinitely postponed.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 351

3 free questions a day, no account

Hearings

History

  1. Currently Indefinitely Postponed
  2. Reported Out of Committee House of Origin
  3. Read for the Second Time and placed on the Calendar (Healthcare)
  4. Read for the first time and referred to the Senate Committee on Healthcare
  5. Pending Committee Action in House of Origin (Healthcare)

Sponsors

  • April Weaver (R) · sponsor
  • Weaver

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 351 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 351 free

Or ask your AI assistant about SB 351 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice